Status and phase
Conditions
Treatments
About
This study will evaluate the safety and efficacy of MIL62 in patients with Neuromyelitis Optica Spectrum Disorder.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
140 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Dehui Huang, doctor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal